Towards the development of vaccines against Helicobacter pylori: Status and issues

Current Opinion in Investigational Drugs

Volumn 2, Issue 1, 2001, Pages 40-44

  Del Giudice, G ^a  

^a CHIRON VACCINES   (Italy)

Author keywords

CagA; Gram negative bacteria; H felis; H pylori; Prophylactic vaccine; Therapeutic vaccine

Indexed keywords

ANTIBIOTIC AGENT; CD4 ANTIGEN; GAMMA INTERFERON; HELICOBACTER PYLORI VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

BACTERIAL IMMUNITY; CHRONIC GASTRITIS; CLINICAL TRIAL; DISEASE MODEL; DRUG MECHANISM; DRUG SAFETY; DRUG SYNTHESIS; ENDEMIC DISEASE; FEASIBILITY STUDY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; NONHUMAN; PEPTIC ULCER; POPULATION RISK; REVIEW; STOMACH CANCER; STOMACH DISEASE; VACCINATION;

ANIMALS; BACTERIAL VACCINES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 0035148296     PISSN: 09678298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Helicobacter pylori
2. Epidemiology of Helicobacter pylori: Acquisition, transmission, population prevalence and disease-to-infection ratio
3. Therapy of Helicobacter pylori: Current status and issues
4. Analysis of the genetic diversity of Helicobacter pylori: The tale of two genomes
5. Helicobacter pylori: Pathogenic determinants and strategies for vaccine design
6. Helicobacter pylori, virulence and genetic geography
7. Mechanisms of Helicobacter pylori infection: Bacterial factors
8. Relationship between Helicobacter pylori, atrophic gastritis and gastric cancer
9. Host response and vaccine development to Helicobacter pylori infection
10. Identification of vaccine targets
11. Molecular biology of microbial ureases
12. Effect of gastric pH on urease-dependent colonization of gnotobiotic piglets by Helicobacter pylori
13. Serologic IgG response to urease in Helicobacter pylori-infected persons from Mexico
14. T-helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease
15. Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T-cell clones from the antrum of chronic gastritis patients with or without peptic ulcer
16. Characterization of a Helicobacter pylori neutrophil-activating protein
17. The Helicobacter pylori neutrophil-activating protein is an iron-binding protein with dodecameric structure
18. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor
19. Challenge model for H pylori infection in human volunteers
20. Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors
21. Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan
22. Altered states: Involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori
23. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells
24. Tyrosine phosphorylation of Helicobacter pylori CagA antigen after cag-driven host cell translocation
25. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion
26. Translocation of the Helicobacter CagA protein in gastric epithelial cells by a type IV secretion apparatus
27. Towards deciphering the Helicobacter pylori cytotoxin
28. Morphologic differentiation of HL-60 cells is associated with appearance of RPTPβ and induction of Helicobacter pylori VacA sensitivity
29. Natural and experimental Helicobacter mustelae reinfection following successful antimicrobial eradication in ferrets
30. Rapid recurrence of Helicobacter pylori infection in Peruvian patients after successful eradication. Gastrointestinal Physiology Working Group of the Universidad Peruana Cayetano Heredia and the Johns Hopkins University
31. Expression of B7-1 and B7-2 costimulatory molecules by human gastric epithelial cells: Potential role of CD4+ T-cell activation during Helicobacter pylori infection
32. An increased number of follicles containing activated CD69+ helper T-cells and proliferating CD71+ B-cells are found in H pylori-infected gastric mucosa
33. Immunohistochemical study of lymphocyte populations infiltrating the gastric mucosa of beagle dogs experimentally infected with Helicobacter pylori
34. Lymphocytes in the human gastric mucosa during Helicobacter pylori infection have a T-helper cell 1 phenotype
35. Antrum and corpus mucosa-infiltrating CD4+ lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype
36. Local cytokine response in Helicobacter pylori infected subjects
37. Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice
38. Immunization of BALB/c mice with Helicobacter urease B induces a T-helper 2 response absent in Helicobacter infection
39. A predominant Th1 type of immune response is induced early during acute Helicobacter pylori infection in rhesus macaques
40. Rapid development of severe hyperplastic gastritis with gastric epithelial dedifferentiation in Helicobacter felis-infected IL-10(-/-) mice
41. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-γ gene-deficient mice
42. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy
43. Molecular mimicry between Helicobacter pylori and the host
44. The design of vaccines against Helicobacter pylori and their development
45. Immunization with recombinant Helicobacter pylori urease in specific-pathogen-free rhesus monkeys (Macaca mulatta)
46. Helicobacter pylori infection in IgA deficiency: Lack of role for the secretory immune system
47. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses
48. Antibody-independent protective mucosal immunity to gastric Helicobacter infection in mice
49. Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies
50. Gastric mucosal α4β7-integrin-positive CD4 T lymphocytes and immune protection against Helicobacter infection in mice
51. Failure of immunization against Helicobacter infection in IL-4 deficient mice: Evidence for a Th2 immune response as the bias for protective immunity
52. Safety and immunogenicity of a Helicobacter pylori vaccine in human volunteers
53. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults